Dermatology, Procedural Dermatology · Great Neck, NY
NPI
1407940687
Since 2006
Specialty
Dermatology, Procedural Dermatology
Code 207NS0135X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
310 E Shore Rd, 204
Great Neck, NY, 11023
Phone (516) 829-4464
Medicare paid, 2024
$544K
10,037 services
Medicare patients, 2024
2,068
Average age 78
Drug cost, 2024
$286K
2,175 prescriptions
Company payments, 2025
$2,192
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy S Wolfin was code 17003 (destruction skin lesion), 3,604 times for 612 patients. In total Nancy S Wolfin billed 10,037 services in 41 codes, and Medicare paid $544K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,604 | 612 | $6.17 | $22K |
| 99214 Office E&M - Established | Office | 2,294 | 1,568 | $105.53 | $242K |
| 17000 Destruction Skin Lesion | Office | 1,527 | 922 | $57.35 | $88K |
| 99213 Office E&M - Established | Office | 916 | 521 | $77.04 | $71K |
| 99212 Office E&M - Established | Office | 490 | 390 | $48.66 | $24K |
| 11102 Skin Biopsy | Office | 342 | 291 | $88.46 | $30K |
| 17110 Destruction Skin Lesion | Office | 213 | 183 | $86.32 | $18K |
| 99203 Office E&M - New | Office | 85 | 85 | $84.41 | $7,175 |
| 10040 Removal or Shaving of Skin Growth | Office | 84 | 78 | $57.08 | $4,795 |
| 17260 Destruction Skin Lesion | Office | 55 | 44 | $83.03 | $4,567 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 54 | 28 | $0.70 | $37.81 |
| 11103 Skin Biopsy | Office | 54 | 44 | $47.82 | $2,582 |
| 99204 Office E&M - New | Office | 44 | 44 | $139.60 | $6,142 |
| 11900 Skin | Office | 42 | 26 | $43.17 | $1,813 |
| 97597 Debridement | Office | 22 | 18 | $88.57 | $1,949 |
By year: 2022 $657K for 11,048 services; 2023 $671K for 11,100 services; 2024 $544K for 10,037 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nancy S Wolfin prescribed most often to Medicare patients was Triamcinolone Acetonide, with 210 prescriptions and refills. In total Nancy S Wolfin wrote 2,175 Medicare prescriptions that cost $286K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 210 | 225 | 142 | $2,846 |
| Ketoconazole Generic | 198 | 216 | 99 | $4,489 |
| Betamethasone Dipropionate Generic | 197 | 209 | 100 | $7,094 |
| Ciclopirox Ciclopirox Olamine | 133 | 143 | 68 | $3,205 |
| Mometasone Furoate Generic | 128 | 135 | 90 | $2,602 |
| Mupirocin Generic | 119 | 119 | 89 | $914 |
| Fluticasone Propionate Generic | 106 | 109 | 68 | $2,517 |
| Metronidazole Generic | 95 | 116 | 60 | $4,993 |
| Hydrocortisone Generic | 75 | 77 | 32 | $385 |
| Valacyclovir Valacyclovir Hcl | 72 | 89 | 37 | $801 |
| Halobetasol Propionate Generic | 66 | 66 | 41 | $3,554 |
| Clobetasol Propionate Generic | 64 | 67 | 34 | $3,129 |
| Doxycycline Hyclate Generic | 53 | 86 | 18 | $1,748 |
| Alclometasone Dipropionate Generic | 47 | 54 | 38 | $2,391 |
| Desonide Generic | 46 | 54 | 32 | $2,630 |
Brand drugs: 246 claims; generic drugs: 1,929 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy S Wolfin $2,192 ($2,192 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $297 |
| Incyte Corporation INCY | 13 | $278 |
| Abbvie Inc. ABBV | 9 | $207 |
| Janssen Biotech, Inc. JNJ | 6 | $200 |
| Galderma Laboratories, L.P. GALD.SW | 4 | $188 |
| Journey Medical Corporation DERM | 2 | $180 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $160 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $95.83 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $89.99 |
| Amgen Inc. AMGN | 3 | $84.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.